Back
Cartesian Therapeutics Stock Price Chart
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.
Sell
25
RNAC
Cartesian Therapeutics
Last Price:
12.91
Seasonality Move:
-10.23%
7 Day Trial
ALL ACCESS PASS
$
7
Potential crash warning signs flashing again on my charts
Here's my #1 indicator to try out now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing selling pressure, which indicates risk of future bearish movement.
Cartesian Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.85 | Sell |
| 20-day SMA: | 13.88 | Sell |
| 50-day SMA: | 16.01 | Sell |
| 200-day SMA: | 21.37 | Sell |
| 8-day EMA: | 13.69 | Sell |
| 20-day EMA: | 14.18 | Sell |
| 50-day EMA: | 16.35 | Sell |
| 200-day EMA: | 22.22 | Sell |
Cartesian Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.74 | Sell |
| Relative Strength Index (14 RSI): | 40.66 | Sell |
| Chaikin Money Flow: | -40444 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.28 - 14.54) | Sell |
| Bollinger Bands (100): | (14.39 - 27.07) | Sell |
Cartesian Therapeutics Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cartesian Therapeutics Stock
Is Cartesian Therapeutics Stock a Buy?
- Cartesian Therapeutics share price is 12.98 while RNAC 8-day simple moving average is 13.85, which is a Sell signal.
- The stock price of RNAC is 12.98 while Cartesian Therapeutics 20-day SMA is 13.88, which makes it a Sell.
- Cartesian Therapeutics 50-day simple moving average is 16.01 while RNAC share price is 12.98, making it a Sell technically.
- RNAC stock price is 12.98 and Cartesian Therapeutics 200-day simple moving average is 21.37, creating a Sell signal.
RNAC Technical Analysis vs Fundamental Analysis
Sell
25
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy or a Sell?
-
Cartesian Therapeutics stock is rated a Sell
The current Cartesian Therapeutics [RNAC] share price is $12.98. The Score for RNAC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Cartesian Therapeutics Stock Info
Market Cap:
277.54M
Price in USD:
12.98
Share Volume:
53.5K
Cartesian Therapeutics 52-Week Range
52-Week High:
42.60
52-Week Low:
11.67
Sell
25
Cartesian Therapeutics (RNAC)
is a Sell
Cartesian Therapeutics Share Price Forecast
-
What is the Cartesian Therapeutics stock price today?
The Cartesian Therapeutics stock price is 12.98 USD today. -
Will RNAC stock go up or go down?
Cartesian Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cartesian Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cartesian Therapeutics is overvalued.
Is Cartesian Therapeutics Stock a Buy?
- Cartesian Therapeutics share price is 12.98 while RNAC 8-day exponential moving average is 13.69, which is a Sell signal.
- The stock price of RNAC is 12.98 while Cartesian Therapeutics 20-day EMA is 14.18, which makes it a Sell.
- Cartesian Therapeutics 50-day exponential moving average is 16.35 while RNAC share price is 12.98, making it a Sell technically.
- RNAC stock price is 12.98 and Cartesian Therapeutics 200-day simple moving average is 22.22, creating a Sell signal.
Fundamental Analysis of Cartesian Therapeutics
Is Cartesian Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $2.16 per share.
Technical Analysis of Cartesian Therapeutics
Should I short Cartesian Therapeutics stock?
- RNAC Moving Average Covergence Divergence (MACD) indicator is -0.74, suggesting Cartesian Therapeutics is a Sell
- Cartesian Therapeutics Relative Strength Index (RSI) is 40.66, which suggest Cartesian Therapeutics is oversold
- The Bollinger Bands (25) for Cartesian Therapeutics is (13.28 - 14.54), which suggest Cartesian Therapeutics is a Sell
- The Bollinger Bands (100) for Cartesian Therapeutics is (14.39 - 27.07), which suggest Cartesian Therapeutics is a Sell
* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.